Clinical Trial Update: Arginine Therapy in Sickle Cell Disease-VOC Clinical Trial [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating arginine therapy for vaso-occlusive pain episodes in sickle cell disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sickle Cell Disease

Drugs mentioned

• L-Arginine (L-Arginine)

Snippet

Sponsor: UCSF Benioff Children's Hospital Oakland | Conditions: Vaso-occlusive Pain Episodes | Phase 2 | Status: COMPLETED